New CRISPR, gene therapy results strengthen potential for treatment of blood diseases

Three people with the inherited blood diseases sickle cell and beta thalassemia remain free of burdensome blood transfusions and their worst symptoms, months after receiving an infusion of genetically modified stem cells.